Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria T Rugeles

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Immunology|July 31, 2007
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11Carlos J Montoya, David Pollard, Jeffrey Martinson, et al.
Critical Care Medicine|December 25, 2013
Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study*Henry G Gomez, Sandra M Gonzalez, Jessica M Londoño, et al.
Plos One|December 2, 2021
A specific structure and high richness characterize intestinal microbiota of HIV-exposed seronegative individualsTulio J Lopera, Jorge A Lujan, Eduardo Zurek, et al.
Molecules (Basel, Switzerland)|November 27, 2021
Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral MechanismsDamariz Marín-Palma, Jorge H Tabares-Guevara, María I Zapata-Cardona, et al.
Frontiers in Immunology|January 9, 2023
Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in ColombiaMaría I Zapata-Cardona, Lizdany Flórez-Álvarez, Tulio J Lopera, et al.
AIMS Microbiology|March 9, 2023
In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approachMaria I Zapata-Cardona, Lizdany Florez-Alvarez, Ariadna L Guerra-Sandoval, et al.
The Journal of Infection|October 23, 2012
Randomized clinical trial of lovastatin in HIV-infected, HAART naïve patients (NCT00721305)Carlos J Montoya, Edwin A Higuita, Santiago Estrada, et al.
Cellular Immunology|March 13, 2008
Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligandsJeffrey A Martinson, Alejandro Roman-Gonzalez, Allan R Tenorio, et al.
Frontiers in Immunology|January 7, 2025
Immunogenicity of the CoronaVac vaccine in children: a real-world studyWbeimar Aguilar-Jimenez, Ana Lucia Rodriguez-Perea, Mateo Chvatal-Medina, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Immunology|July 31, 2007
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11Carlos J Montoya, David Pollard, Jeffrey Martinson, et al.
Critical Care Medicine|December 25, 2013
Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study*Henry G Gomez, Sandra M Gonzalez, Jessica M Londoño, et al.
Plos One|December 2, 2021
A specific structure and high richness characterize intestinal microbiota of HIV-exposed seronegative individualsTulio J Lopera, Jorge A Lujan, Eduardo Zurek, et al.
Molecules (Basel, Switzerland)|November 27, 2021
Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral MechanismsDamariz Marín-Palma, Jorge H Tabares-Guevara, María I Zapata-Cardona, et al.
Frontiers in Immunology|January 9, 2023
Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in ColombiaMaría I Zapata-Cardona, Lizdany Flórez-Álvarez, Tulio J Lopera, et al.
AIMS Microbiology|March 9, 2023
In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approachMaria I Zapata-Cardona, Lizdany Florez-Alvarez, Ariadna L Guerra-Sandoval, et al.
The Journal of Infection|October 23, 2012
Randomized clinical trial of lovastatin in HIV-infected, HAART naïve patients (NCT00721305)Carlos J Montoya, Edwin A Higuita, Santiago Estrada, et al.
Cellular Immunology|March 13, 2008
Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligandsJeffrey A Martinson, Alejandro Roman-Gonzalez, Allan R Tenorio, et al.
Frontiers in Immunology|January 7, 2025
Immunogenicity of the CoronaVac vaccine in children: a real-world studyWbeimar Aguilar-Jimenez, Ana Lucia Rodriguez-Perea, Mateo Chvatal-Medina, et al.
Pageof 5